{
    "medicine_id": "0930bb46e56f44854e69c157ba861b54e57dece1",
    "platform_id": "DB04915",
    "metadata": {
        "name": "Orbactiv 400 mg 1 Injection powder lyophilized for solution",
        "composition": "400 mg 1 Idronoxil",
        "clinical_particulars": {
            "therapeutic_indications": "Intended for the treatment of various forms of cancer",
            "contraindications": {
                "disease": "NA",
                "pregnancy": "NA",
                "machine_ops": "NA",
                "pharmacodynamics": "Phenoxodiol inhibits proliferation of many cancer cell lines and induces apoptosis by disrupting FLICE inhibitory protein FLIP expression and by caspase dependent and independent degradation of the X linked inhibitor of apoptosis XIAP In addition phenoxodiol sensitizes drug resistant tumour cells to anticancer drugs including paclitaxel carboplatin and gemcitabine",
                "excipients": "NA",
                "incompatibilities": []
            }
        },
        "revision_date": "2023-05-14"
    }
}